XML 24 R31.htm IDEA: XBRL DOCUMENT v3.2.0.727
Basis of Presentation (Details)
12 Months Ended
Dec. 31, 2014
customer
Sep. 02, 2014
item
FDA Warning Letter    
Number of observations   8
Number of identified responses whose accuracy will be determined   2
Gross accounts receivable | Credit concentration risk | International customer    
Certain Significant Risks and Uncertainties    
Number of customers | customer 2  
Concentration risk (as a percent) 35.00%